News & Updates

Show Multimedia Only

Is it safe to administer RSV vax with flu or COVID-19 vaccines in adults?

25 Feb 2025 by

A two-part phase III study in adults aged ≥50 years supports the co-administration of the respiratory syncytial virus (RSV) vaccine, mRNA-1345, with the seasonal standard-dose quadrivalent inactivated influenza vaccine, SIIV4, or the bivalent COVID-19 vaccine, mRNA-1273.214.

Is it safe to administer RSV vax with flu or COVID-19 vaccines in adults?

25 Feb 2025

Baloxavir shows promise in patients with nonsevere influenza

20 Feb 2025

In the treatment of patients with nonsevere influenza virus infection, baloxavir may reduce the risk of hospital admission and shorten the time to symptom relief, according to the results of a systematic review and meta-analysis.

Baloxavir shows promise in patients with nonsevere influenza

20 Feb 2025

Study supports early antiviral therapy in patients with moderate–high HBV viral load

19 Feb 2025

Early treatment with tenofovir alafenamide appears to lower the risk of serious liver-related adverse events in patients with noncirrhotic chronic hepatitis B virus (HBV) infection and moderate or high viraemia, regardless of alanine aminotransferase (ALT) concentrations, according to interim data from the ATTENTION trial conducted in South Korea.

Study supports early antiviral therapy in patients with moderate–high HBV viral load

19 Feb 2025

Antimicrobial stewardship helps reduce postelective caesarean antibiotic use

14 Feb 2025 by

An intervention with antimicrobial stewardship programs (ASPs) can prevent the unnecessary use of antibiotic prophylaxis in women following elective lower section caesarean section (eLSCS) with no adverse effects, according to a Singapore study.

Antimicrobial stewardship helps reduce postelective caesarean antibiotic use

14 Feb 2025

Cefiderocol safe to use in hospitalized children with bacterial infection

05 Feb 2025 by

A 3-hour infusion of cefiderocol in hospitalized paediatric patients is well tolerated and demonstrates activity against clinically relevant Gram-negative species of bacterial infections, reports a phase II study.

Cefiderocol safe to use in hospitalized children with bacterial infection

05 Feb 2025

$Oral noninferior to IV antibiotics for fracture-related infections$

Oral noninferior to IV antibiotics for fracture-related infections

04 Feb 2025

In the treatment of fracture-related infections, outcomes appear to be comparable when using oral vs intravenous (IV) antibiotics, according to a study.

Oral noninferior to IV antibiotics for fracture-related infections

04 Feb 2025

Age, high-risk conditions predict RSV hospitalization in children

04 Feb 2025

Hospitalization due to respiratory syncytial virus (RSV) infection in infants and children is significantly associated with younger age, high-risk conditions, and palivizumab-indicated underlying conditions, according to a study in Japan.

Age, high-risk conditions predict RSV hospitalization in children

04 Feb 2025

Experimental HPV vaccine shrinks high-grade precancerous cervical lesions

02 Feb 2025 by

A novel vaccine that targets HPV type 16 (HPV16) has shown clinical activity against HPV16-positive cervical intraepithelial neoplasia grade 3 (CIN3) in a phase II trial, substantially reducing lesion size.